Paul J. Mellett
2017
In 2017, Paul J. Mellett earned a total compensation of $1.6M as Senior Vice President, Finance & Administration and Chief Financial Officer at Enanta Pharmaceuticals, a 32% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $142,127 |
---|---|
Option Awards | $513,930 |
Salary | $370,728 |
Stock Awards | $557,078 |
Other | $18,551 |
Total | $1,602,414 |
Mellett received $557.1K in stock awards, accounting for 35% of the total pay in 2017.
Mellett also received $142.1K in non-equity incentive plan, $513.9K in option awards, $370.7K in salary and $18.6K in other compensation.
Rankings
In 2017, Paul J. Mellett's compensation ranked 6,635th out of 14,666 executives tracked by ExecPay. In other words, Mellett earned more than 54.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,635 | 55th |
Manufacturing | 2,455 | 58th |
Chemicals And Allied Products | 790 | 62nd |
Drugs | 609 | 65th |
Pharmaceutical Preparations | 480 | 64th |
Mellett's colleagues
We found four more compensation records of executives who worked with Paul J. Mellett at Enanta Pharmaceuticals in 2017.
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019